Release Date: 17/02/14 09:13 Summary: Unaudited Interim Financial Report December 2013 Price Sensitive: No Download Document 114.43KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%